Skip to content

Clinical trials

Bile Duct Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bile Duct Neoplasms Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20162
20173
20192
20202
20221
20235
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Recruiting6
Completed4
Not yet recruiting2
Active, not recruiting1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ASLAN Pharmaceuticals2
Merck Sharp & Dohme LLC2
RenJi Hospital2
Affiliated Hospital of Guangdong Medical University1
Air Force Military Medical University, China1
AstraZeneca1
Chongqing Precision Biotech Co., Ltd1
Curegenix Inc.1
DualityBio Inc.1
First Affiliated Hospital of Zhejiang University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bile Duct Neoplasms24
Cholangiocarcinoma9
Gallbladder Neoplasms8
Biliary Tract Neoplasms7
Pancreatic Neoplasms6
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Esophageal Neoplasms3
Gastrointestinal Neoplasms3

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.